Xiaohe Luo

机构：Ningxia University, Chongqing Three Gorges Central Hospital, Chongqing Three Gorges University · ORCID：0000-0002-7951-9002

发表论文 36 篇 · 总被引 1194 次 · h-index 16

代表论文

• Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK–PPAR-γ–CD36 Pathway (2019 · Diabetes · 被引 100)
• MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability (2017 · Oncogene · 被引 91)
• Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer (2018 · Journal of Medicinal Chemistry · 被引 79)
• The Antitriple Negative Breast cancer Efficacy of Spatholobus suberectus Dunn on ROS‐Induced Noncanonical Inflammasome Pyroptotic Pathway (2021 · Oxidative Medicine and Cellular Longevity · 被引 40)
• Interleukin-1β Promotes Schwann Cells De-Differentiation in Wallerian Degeneration via the c-JUN/AP-1 Pathway (2019 · Frontiers in Cellular Neuroscience · 被引 34)
• Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance (2017 · Diabetes Research and Clinical Practice · 被引 34)